Skip to main content
Premium Trial:

Request an Annual Quote

It's Personal

Boonsri Dickinson speaks with Esther Dyson, asking her about personalized medicine. Dyson says that monitor health and activities is important because “in general what you don’t monitor, you are not going to change.” She adds that having tools to remind people often make it easier.

The Boston Globe also reports that two companies, CVS Caremark and Medco Health Solutions, are moving toward using personalized medicine. CVS plans to offer offering genetic testing services to its pharmacy benefit management program clients and Medco offers genetic tests for the use of two drugs and plans to add four more tests later this year.

HT: Bertalan Meskó

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.